Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

MiR-155 antagomir ameliorates experimental lupus pulmonary hemorrhage

Nov. 14, 2013

ChemoCentryx describes novel small-molecule inhibitors of CCR1 and CCR6

Nov. 13, 2013

Bispecific TNF/IL-17A inhibitor engineered for rheumatoid arthritis

Nov. 12, 2013

ACEA Biosciences' AC-0025 shows antiarthritic activity in vivo

Nov. 11, 2013

Armgo Pharma receives grant from Kennedy's Disease Association

Nov. 8, 2013

RepliCel forms clinical advisory board to support the development of RCT-01

Nov. 6, 2013

New IL-17 production inhibitors disclosed by Mitsubishi Tanabe Pharma

Nov. 5, 2013

Ampio Pharmaceuticals reports data from extension of SPRING study

Nov. 5, 2013

Xoma reports results from two phase II studies in proof-of-concept program for gevokizumab

Nov. 4, 2013

Amgen reports phase I data for AMG-557 in patients with SLE

Oct. 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...